EZH2 Inhibitor EPZ-6438 Synergizes With Anti-Lymphoma Therapies In Preclinical Models
暂无分享，去创建一个
Tim J. Wigle | R. Copeland | R. Pollock | B. Littlefield | A. Raimondi | S. K. Knutson | N. Warholic | C. Klaus | M. Moyer | K. Kuntz | H. Keilhack | M. Scott | Jesse J. Smith | J. J. Smith | L. Johnston | Dorothy Iwanowicz | T. Wigle | Alejandra Raimondi